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+/R899X mice and Bmpr2 +/+ littermate controls (n=3, **P<0.05, Student's t-test, mean +/-SEM). (d-i) DNA and RNA from mouse (mm) and human (hs) PASMC were analyzed by PCR amplification and direct sequencing. DNA shows a heterozygous mutation (arrowed), with approximately equal peak heights for the wildtype and mutant alleles (d,g). In RNA from the same cells, the mutant peak is almost undetectable (e,h), indicating likely degradation due to nonsense-mediated mRNA decay (NMD). NMD is dependent on de novo protein translation. Inhibition of translation with puromycin resulted in (f) complete recovery of the mutant transcript in mouse PASMC and (i) partial recovery in human cells. +/R899X pulmonary endothelial monolayers to HRP, assessed as a measure of colorimetric absorbance after incubation periods ranging from 30 minutes to 2 hours with or without BMP9 (20 ng/mL) and/or LPS (400 ng/mL) (n=3). AU: Arbitrary units. (e) Quantification of proliferation of PASMCs isolated from the lungs of WT and Bmpr2 +/R899X mice (n=3-4). (f) Quantification of proliferation of PASMCs from Bmpr2 +/R899X mice cultured in DMEM with 10% FBS, with or without 10 ng/mL BMP4 or 1 ng/mL BMP9 (n=3, *P<0.05, 1-way ANOVA, Dunnett's post test versus 10% FBS control).
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